List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 560 studies with search of: "Irinotecan"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed High Dose CPT-11 in Recurrent Unresectable Malignant Glioma
Conditions: Malignant Glioma;   Unresectable
Interventions: Drug: Irinotecan;   Drug: CPT-11;   Drug: Camptosar
2 Recruiting Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC
Condition: Colorectal Cancer
Interventions: Drug: Irinotecan;   Drug: 5-Fluorouracil;   Drug: Leucovorin;   Drug: Capecitabine;   Drug: Bevacizumab;   Drug: Bevacizumab;   Drug: Irinotecan
3 Recruiting Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: S-1 + irinotecan;   Drug: irinotecan
4 Recruiting Chemoembolization, Irinotecan Bead, Second Line Chemotherapy Treatment of Unresectable Metastatic Colorectal Cancer
Condition: Unresectable Metastatic Colo-Rectal Cancer
Interventions: Procedure: Chemoembolization with irinotecan Bead;   Drug: Irinotecan
5 Active, not recruiting Dose-Finding Study of E7070 in Combination With Irinotecan
Condition: Cancer
Interventions: Drug: E7070 + irinotecan combination;   Drug: Irinotecan + E7070 combination;   Drug: Irinotecan + E7070 combination
6 Completed Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Temodar, O6-BG, and Irinotecan
7 Active, not recruiting Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide
Condition: Glioblastoma
Intervention: Drug: Temodar and Irinotecan
8 Active, not recruiting Ph I SU011248 + Irinotecan in Treatment of Pts w MG
Condition: Glioblastoma
Intervention: Drug: SU011248 & Irinotecan
9 Recruiting Avastin in Combo w XRT & Temozolomide , Followed by Avastin, Temozolomide & Irinotecan for GBM & Gliosarcomas
Conditions: Glioblastoma;   Gliosarcoma;   Brain Tumor
Intervention: Drug: Avastin, radiation, temozolomide, and irinotecan
10 Active, not recruiting Irinotecan (Camptosar) in Patients With Advanced Sarcomas
Condition: Sarcoma
Intervention: Drug: Irinotecan
11 Recruiting Safety Study of ON 01910.Na in Combination With Irinotecan or Oxaliplatin
Condition: Advanced Solid Tumors
Interventions: Drug: ON 01910.Na and irinotecan;   Drug: ON 01910.Na and oxaliplatin
12 Recruiting Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC
Condition: Colorectal Cancer
Interventions: Drug: Irinotecan;   Drug: Capecitabine;   Drug: Cetuximab;   Drug: Oxaliplatin
13 Recruiting Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Interventions: Drug: Irinotecan hydrochloride;   Drug: Cisplatin;   Drug: Krestin
14 Active, not recruiting Cetuximab Combined With Irinotecan in First-Line Therapy for Metastatic Colorectal Cancer (CRYSTAL)
Condition: EGFR-Expressing Metastatic Colorectal Cancer
Interventions: Drug: Cetuximab, 5-Fluorouracil, Folinic acid, Irinotecan;   Drug: 5-Fluorouracil, Folinic acid, Irinotecan
15 Completed Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.
Condition: Colorectal Neoplasms
Interventions: Drug: Modified Bolus 5-FU/LV with Irinotecan;   Drug: FOLFIRI + bevacizumab;   Drug: miFL + bevacizumab;   Drug: Infusional 5-FU/LV with Irinotecan;   Drug: Oral Capecitabine with Irinotecan
16 Recruiting Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: Irinotecan;   Drug: Avastin;   Drug: Erbitux
17 Recruiting Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme
Condition: Malignant Gliomas
Interventions: Drug: Irinotecan;   Drug: Lenalidomide
18 Active, not recruiting Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Temodar, Etoposide & Irinotecan
19 Active, not recruiting A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: Bevacizumab;   Drug: Irinotecan;   Drug: Capecitabine
20 Not yet recruiting Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc
Condition: Colorectal Cancer
Interventions: Drug: Oxaliplatin;   Drug: 5-Fluorouracil;   Drug: Leucovorin;   Drug: Bevacizumab;   Drug: Irinotecan;   Drug: Cetuximab

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services